Highlights from ACC 15 Scientific Sessions: Part 1

References (8)

1. ACC.15 Convocation Speech: Patrick T. O'Gara, MD, MACC. From ACC News
2. ACC.15 Convocation Speech: Kim Allan Williams, Sr., MD, FACC. From ACC News
3. Blendon RJ, Benson JM, Hero JO. Public Trust in Physicians-U.S. medicine in international perspective. N Engl J Med 2014; 371: 1570-2. [CrossRef] 4. Mack JM, Leon MB, Smith CR, Miller C, Moses JW, Tuzcu EM, et al. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 2015 Mar 15. pii: S0140-6736(15)60308-7. doi: 10.1016/S0140- 6736(15)60308-7. [Epub ahead of print]. [CrossRef] 5. Kapadia SR, Leon MB, Makkar RR, Tuzcu EM, Svensson LG, Kodali S, et al. 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 2015 Mar 15. pii: S0140-6736(15)60290-2. doi: 10.1016/S0140-6736(15) 60290-2. [Epub ahead of print]
4. Kodali S, on behalf of The PARTNER Trial Investigators. The first report of SAPIEN3 in the United States,and the first report on intermediate-risk TAVR patients. Presented at the American College of Cardiology's (ACC) 64th Annual Scientific Session in San Diego. March 15, 2015
5. Barker CM, Reardon MJ. The CoreValve US pivotal trial. Semin Thorac Cardiovasc Surg 2014; 26: 179-86. [CrossRef] 8. Reardon M. A Randomized Comparison of Self-expanding Transcatheter and Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis Deemed at Increased Risk for Surgery 2-Year Outcomes. Presented at the American College of Cardiology's (ACC) 64th Annual Scientific Session in San Diego CA. March 2015
6. Lansky AJ. First report of the DEFLECT III trial results: A prospective randomized evaluation of The TriGuardTM HDH embolic DEFLECTion device during transcatheter aortic valve replacement. Presented at the American College of Cardiology's (ACC) 64th Annual Scientific Session in San Diego CA. March 2015
7. Sorajja P. Transcatheter Valve Therapy (TVT) Registry as a real life experience on MitraClip device. Presented at the American College of Cardiology's (ACC) 64th Annual Scientific Session in San Diego CA. March 2015
8. Douglas PS, Hoffmann U, Patel MR, Mark DB, Al-Khalidi HR, Cavanaugh B, et al. Outcomes of anatomical versus functional testing for coronary artery disease. N Engl J Med 2015; 372: 1291-300. [CrossRef] 12. S